Today's AI verdict on what's driving $HCAT, plus how loud the X conversation is and which way it's leaning.
What to watch: Vitalware sale close timing (terms, regulatory approvals, escrow) and post-divestiture capital-deployment commentary — special dividend, buyback, or reinvestment. Aug 6 Q2 print would confirm the underlying analytics-platform revenue base. Bear: the Vitalware sale falls through, or the remaining business reveals worse underlying revenue trajectory than the segment reporting implied.
On the calendar: 2026-08-06 — Q2 earnings
Plain-English summary of the business — what they sell and how they make money.
Where Medical - Healthcare Information Services sits in its cycle right now — and what that implies for $HCAT.
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Volume, range, and moving-average position — the technical setup driving short-term moves.
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
Explore the broader themes this ticker is being talked about under.
Peers in the same group — one click to compare setups, fundamentals, and chatter.
No standout posts about $HCAT on X in the last 7 days.
